Patents by Inventor Niek Verweij

Niek Verweij has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors
    Patent number: 11773393
    Abstract: The present disclosure provides methods of treating subjects having a liver disease, and methods of identifying subjects having an increased risk of developing liver disease.
    Type: Grant
    Filed: March 31, 2022
    Date of Patent: October 3, 2023
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Niek Verweij, Luca Andrea Lotta, Aris Baras, Mary Haas, Jonas Nielsen, Olukayode Sosina, Adam Locke
  • Treatment of Liver Diseases With CAMP Responsive Element Binding Protein 3 Like 3 (CREB3L3) Inhibitors
    Publication number: 20230160012
    Abstract: The present disclosure provides methods of treating subjects having a liver disease with a CAMP Responsive Element Binding Protein 3 Like 3 (CREB3L3) inhibitor, and methods of identifying subjects having an increased risk of developing a liver disease.
    Type: Application
    Filed: August 29, 2022
    Publication date: May 25, 2023
    Inventors: Niek Verweij, Luca Andrea Lotta, Aris Baras
  • Methods Of Treating Liver Diseases With Phosphodiesterase 3B (PDE3B) Inhibitors
    Publication number: 20220364099
    Abstract: The present disclosure provides methods of treating a subject having a liver disease or type 2 diabetes, and methods of identifying subjects having an increased risk of developing a liver disease or type 2 diabetes.
    Type: Application
    Filed: May 10, 2022
    Publication date: November 17, 2022
    Inventors: Niek Verweij, Olukayode Sosina, Parsa Akbari, Adam Locke, Aris Baras, Luca Andrea Lotta
  • Treatment Of Liver Disease With Mitochondrial Glycerol-3-Phosphate Acyltransferase (GPAM) Inhibitors
    Publication number: 20220307032
    Abstract: The present disclosure provides methods of treating subjects having liver disease, and methods of identifying subjects having an increased risk of developing liver disease.
    Type: Application
    Filed: February 25, 2022
    Publication date: September 29, 2022
    Inventors: Luca Andrea Lotta, Niek Verweij, Colm O'Dushlaine, Jonathan Marchini, Aris Baras
  • Treatment Of Liver Disease With Ring Finger Protein 213 (RNF213) Inhibitors
    Publication number: 20220307033
    Abstract: The present disclosure provides methods of treating subjects having a liver disease, and methods of identifying subjects having an increased risk of developing a liver disease.
    Type: Application
    Filed: March 1, 2022
    Publication date: September 29, 2022
    Inventors: Luca Andrea Lotta, Niek Verweij, Manuel Allen Revez Ferreira, Aris Baras
  • Treatment of Liver Diseases With Cell Death Inducing DFFA Like Effector B (CIDEB) Inhibitors
    Publication number: 20220282253
    Abstract: The present disclosure provides methods of treating subjects having a liver disease, and methods of identifying subjects having an increased risk of developing liver disease.
    Type: Application
    Filed: March 31, 2022
    Publication date: September 8, 2022
    Inventors: Niek Verweij, Luca Andrea Lotta, Aris Baras, Mary Haas, Jonas Nielsen, Olukayode Sosina, Adam Locke
  • Treatment of Liver Diseases With Cell Death Inducing DFFA Like Effector B (CIDEB) Inhibitors
    Publication number: 20220220474
    Abstract: The present disclosure provides methods of treating subjects having a liver disease, and methods of identifying subjects having an increased risk of developing liver disease.
    Type: Application
    Filed: December 22, 2021
    Publication date: July 14, 2022
    Inventors: Niek Verweij, Luca Andrea Lotta, Aris Baras, Mary Haas, Jonas Nielsen, Olukayode Sosina, Adam Locke